Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl August Brensing

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|September 21, 2002
Diabetic nephropathyKarl August Brensing, Peter Raab, Ulrich Frotscher
European Journal of Gastroenterology & Hepatology|October 2, 2009
Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: a retrospective analysisBeate Appenrodt, Julia Zielinski, Karl August Brensing, et al.
The American Journal of Gastroenterology|June 18, 2003
Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shuntingMichael Schepke, Felix Roth, Rolf Fimmers, et al.
Journal of Nephrology|January 23, 2004
Cholesterol metabolism in patients with chronic renal failure on hemodialysisArina Igel-Korcagova, Peter Raab, Karl August Brensing, et al.
Digestion|July 11, 2003
Prognostic impact of renal impairment and sodium imbalance in patients undergoing transjugular intrahepatic portosystemic shunting for the prevention of variceal rebleedingMichael Schepke, Felix Roth, Lydia Koch, et al.
European Journal of Gastroenterology & Hepatology|August 10, 2002
Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysisKarl August Brensing, Peter Raab, Jochen Textor, et al.
Clinical Kidney Journal|December 4, 2023
Neutralizing response against SARS-CoV-2 Omicron BA.5 and XBB.1.5 in hemodialysis patientsPatrick Affeldt, Karl August Brensing, Eva Heger, et al.
Microorganisms|April 3, 2021
Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgGKirsten Alexandra Eberhardt, Felix Dewald, Eva Heger, et al.
Viruses|December 23, 2022
Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant RecipientsPatrick Affeldt, Felix Carlo Koehler, Karl August Brensing, et al.
Microorganisms|January 21, 2022
Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant RecipientsPatrick Affeldt, Felix Carlo Koehler, Karl August Brensing, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|September 21, 2002
Diabetic nephropathyKarl August Brensing, Peter Raab, Ulrich Frotscher
European Journal of Gastroenterology & Hepatology|October 2, 2009
Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: a retrospective analysisBeate Appenrodt, Julia Zielinski, Karl August Brensing, et al.
The American Journal of Gastroenterology|June 18, 2003
Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shuntingMichael Schepke, Felix Roth, Rolf Fimmers, et al.
Journal of Nephrology|January 23, 2004
Cholesterol metabolism in patients with chronic renal failure on hemodialysisArina Igel-Korcagova, Peter Raab, Karl August Brensing, et al.
Digestion|July 11, 2003
Prognostic impact of renal impairment and sodium imbalance in patients undergoing transjugular intrahepatic portosystemic shunting for the prevention of variceal rebleedingMichael Schepke, Felix Roth, Lydia Koch, et al.
European Journal of Gastroenterology & Hepatology|August 10, 2002
Prospective evaluation of a clinical score for 60-day mortality after transjugular intrahepatic portosystemic stent-shunt: Bonn TIPSS early mortality analysisKarl August Brensing, Peter Raab, Jochen Textor, et al.
Clinical Kidney Journal|December 4, 2023
Neutralizing response against SARS-CoV-2 Omicron BA.5 and XBB.1.5 in hemodialysis patientsPatrick Affeldt, Karl August Brensing, Eva Heger, et al.
Microorganisms|April 3, 2021
Evaluation of a New Spike (S)-Protein-Based Commercial Immunoassay for the Detection of Anti-SARS-CoV-2 IgGKirsten Alexandra Eberhardt, Felix Dewald, Eva Heger, et al.
Viruses|December 23, 2022
Immune Response to Third and Fourth COVID-19 Vaccination in Hemodialysis Patients and Kidney Transplant RecipientsPatrick Affeldt, Felix Carlo Koehler, Karl August Brensing, et al.
Microorganisms|January 21, 2022
Immune Responses to SARS-CoV-2 Infection and Vaccination in Dialysis Patients and Kidney Transplant RecipientsPatrick Affeldt, Felix Carlo Koehler, Karl August Brensing, et al.
Pageof 1